Golden
Theranos

Theranos

Theranos was a privately held health technology corporation.

Theranos was a privately held health technology corporation.

Founded in 2003 by then-19-year-old Elizabeth Holmes, Theranos raised more than US$700 million from venture capitalists and private investors, resulting in a $10 billion valuation at its peak in 2013 and 2014. Investors and the media hyped Theranos as a breakthrough in the large blood-testing market, where the U.S. diagnostic-lab industry posts annual sales of over $70 billion. Theranos claimed its technology was revolutionary and that its tests required only about 1/100 to 1/1,000 of the amount of blood that would ordinarily be needed and cost far less than existing tests. 



In October 2015 investigative reporter John Carreyrou of The Wall Street Journal questioned the validity of Theranos' technology. The company faced a string of legal and commercial challenges from medical authorities, investors, the U.S. Securities and Exchange Commission (SEC), Centers for Medicare and Medicaid Services (CMS), state attorneys general, former business partners, patients, and others. By June 2016, it was estimated that Holmes's personal net worth had dropped from $4.5 billion to virtually nothing. The company was near bankruptcy until it received a $100 million investment from Fortress Investment Group in 2017. In September 2018, the company ceased operations. 



In July 2016, Theranos received sanctions from the CMS, including the revocation of its CLIA certificate and prohibition of Holmes and other company officials from owning or operating a laboratory for two years. Theranos announced it would close its laboratory operations and wellness centers to work on miniature medical testing machines. In April 2017, Theranos said it had reached a settlement agreement with CMS. Following the CMS sanctions, the Walgreens pharmacy chain terminated its contract with Theranos and filed a lawsuit claiming continuous breaches of contract. The suit was settled out of court, with Theranos compensating Walgreens for a much smaller amount than the claimed $140 million, reported at about $30 million. On March 14, 2018, Theranos, Holmes, and former company president Ramesh "Sunny" Balwani were charged with "massive fraud" by the SEC. One section of the complaint says Holmes falsely claimed in 2014 that the company had annual revenues of $100 million, a thousand times more than the actual figure of $100,000. Theranos and Holmes agreed to resolve the charges against them, with Holmes paying a fine of $500,000, returning the remaining 18.9 million shares that she held, relinquishing her control of the company, and being barred from being an officer or director of any public company for ten years. According to the agreement, if Theranos were acquired or otherwise liquidated, Holmes would not profit from her ownership until more than $750 million was returned to investors and other preferred shareholders. Theranos and Holmes neither admitted nor denied the allegations in the SEC's complaint. Balwani did not settle. On June 15, 2018, the U.S. Attorney for the Northern District of California announced the indictment of Holmes on wire fraud and conspiracy charges. Balwani was also indicted on the same charges.



Theranos ceased operations on August 31, 2018, with its General Counsel and new CEO David Taylor and a few support staff remaining on payroll for a few more days.

Timeline

June 15, 2018

On June 15, 2018, the U.S. Attorney for the Northern District of California announced the indictment of Holmes on wire fraud and conspiracy charges.

June 15, 2018

On June 15, 2018, the U.S. Attorney for the Northern District of California announced the indictment of Holmes on wire fraud and conspiracy charges.

2017

The company was near bankruptcy until it received a $100 million investment from Fortress Investment Group in 2017.

2017

The company was near bankruptcy until it received a $100 million investment from Fortress Investment Group in 2017.

June 2016

By June 2016, it was estimated that Holmes's personal net worth had dropped from $4.5 billion to virtually nothing.

June 2016

By June 2016, it was estimated that Holmes's personal net worth had dropped from $4.5 billion to virtually nothing.

2014

One section of the complaint says Holmes falsely claimed in 2014 that the company had annual revenues of $100 million, a thousand times more than the actual figure of $100,000.

2014

One section of the complaint says Holmes falsely claimed in 2014 that the company had annual revenues of $100 million, a thousand times more than the actual figure of $100,000.

2003

Founded in 2003 by then-19-year-old Elizabeth Holmes, Theranos raised more than US$700 million from venture capitalists and private investors, resulting in a $10 billion valuation at its peak in 2013 and 2014.

2003

Founded in 2003 by then-19-year-old Elizabeth Holmes, Theranos raised more than US$700 million from venture capitalists and private investors, resulting in a $10 billion valuation at its peak in 2013 and 2014.

People

Name
Role
Related Golden topics

Achal Deo

Employee



Aditi Shah

Employee



AJ Dos Santos

Investor



Al Eisaian

Investor



Alan Yip

Employee



Ameet Juriani

Employee



Amy Ta

Employee



Ana Arriola

Employee



Anam Khan

Employee



Andre DSouza

Employee



Andrew Drake

Employee



Andy Li

Employee



Aneesha Narra

Employee



Angela Ha

Employee



Angelica Cardenas

Employee



Ann Yih

Employee



Aparna Velikkettil

Employee



Aravind Tungaturti

Employee



Ashruti Gupta

Employee



Bob Shapiro

Investor



Bradley Griffith

Employee



Brian Kutner

Employee



Chandan Shee

Employee



Chi Nguyen

Employee



Cole Hartman

Employee



SHOW ALL (166)

Further reading

Title
Author
Link
Type
Date









Documentaries, videos and podcasts

Title
Date
Link





Companies

Company
CEO
Location
Products/Services









References